Common Stock, Shares, Outstanding of VBI Vaccines Inc/BC from 29 Apr 2016 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
VBI Vaccines Inc/BC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 29 Apr 2016 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Common Stock, Shares, Outstanding for the quarter ending 31 Mar 2024 was 25,236,766, a 193% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 25,236,766 +16,628,227 +193% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 23,918,983 +15,310,444 +178% 31 Dec 2023 10-Q 15 May 2024 2024 Q1
Q3 2023 23,339,220 -234,918,274 -91% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 8,608,539 -249,648,955 -97% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 8,608,539 -249,648,955 -97% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 8,608,539 -249,641,734 -97% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 258,257,494 +952,726 +0.37% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 258,257,494 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 258,257,494 +4,062,059 +1.6% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 258,250,273 +11,211,263 +4.5% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 257,304,768 +15,265,288 +6.3% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q1 2021 254,195,435 +75,819,765 +43% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 247,039,010 +68,781,811 +39% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 242,039,480 +63,782,281 +36% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 230,648,396 +132,891,197 +136% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 178,375,670 +80,713,783 +83% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 178,257,199 +80,913,422 +83% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 178,257,199 +113,873,808 +177% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 97,757,199 +33,373,808 +52% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 97,661,887 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 97,343,777 +33,264,996 +52% 31 Dec 2018 10-Q 06 Nov 2019 2019 Q3
Q3 2018 64,383,391 +24,154,020 +60% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 64,383,391 +24,154,020 +60% 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q4 2017 64,078,781 +24,060,286 +60% 31 Dec 2017 10-Q 09 Nov 2018 2018 Q3
Q3 2017 40,229,371 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 40,229,371 30 Jun 2017 10-Q 31 Jul 2017 2017 Q2
Q1 2017 40,060,622 +21,145,512 +112% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 40,018,495 31 Dec 2016 10-Q 13 Nov 2017 2017 Q3
Q1 2016 18,915,110 29 Apr 2016 10-K 20 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.